Introduction {#s1}
============

Decades of research using *Escherichia coli* (*Eco*) as a model system inform most of our understanding of how bacteria control transcription initiation. First, dissociable promoter specificity subunits, σ factors, direct the catalytic core of the RNA polymerase (RNAP) to promoter DNA sites and play a key role in unwinding the DNA duplex to create the transcription bubble in the RNAP holoenzyme open promoter complex (RPo) ([@bib16]). Second, DNA-binding transcription factors either activate or repress the initiation rate ([@bib6]).

The majority of transcription activators characterized to date are dimeric proteins that bind operators upstream of the promoter −35 element and directly contact the RNAP α subunit ([@bib13]), the σ~4~ domain positioned at the −35 element, or both ([@bib35]; [@bib12]; [@bib25]). Activators can accelerate initiation by stabilizing the initial RNAP/promoter complex, by stimulating the isomerization of the initial RNAP/promoter complex to RPo (i.e., unwinding the duplex DNA to form the transcription bubble), or both ([@bib30]; [@bib40]).

CarD, first identified as a regulator of ribosomal RNA (rRNA) transcription in *Mycobacterium tuberculosis* (*Mtb*), is a transcriptional activator widely distributed among bacterial species, including *Thermus* species ([@bib45]; [@bib44]), but is absent in *Eco* ([Table 1](#tbl1){ref-type="table"}). CarD is a global regulator ([@bib44]) that is an essential protein in *Mtb* ([@bib45]), the causative agent of tuberculosis. A deeper understanding of the CarD functional mechanism and its role in the *Mtb* transcription program is therefore warranted.10.7554/eLife.08505.003Table 1.Distribution of CarD in bacterial phyla**DOI:** [http://dx.doi.org/10.7554/eLife.08505.003](10.7554/eLife.08505.003)Phyla[\*](#tblfn1){ref-type="table-fn"}Clades and colloquial names noted. Select genera within some phyla are also listedCarD presence in phyla\# of completed genomes and draft assemblies[†](#tblfn2){ref-type="table-fn"}**Acidobacteria/Fibrobacterdiderm Gram−Yes (only Acidobacteria)24Actinobacteriamonoderm, high G + C Gram+: *Streptomyces, Mycobacteria*Yes932Aquificaediderm Gram−: glidobacteriaYes16**Bacteroidetesdiderm Gram−: Green sulfur bacteriaNo468Caldisericadiderm Gram−No2**Chlamydiaediderm Gram− Planctobacteria: *Chlamydia trachomatis*Yes21**Chlorobididerm Gram−No12Chloroflexididerm Gram−: glydobacteriaNo32Chrysiogenetesdiderm Gram−: *Desulfurispirillum*No2**Cyanobacteria**[‡](#tblfn3){ref-type="table-fn"}**diderm Gram−: glydobacteriaYes103**Deferribacteresdiderm Gram−No6**Deinococcus--Thermusdiderm Gram−: glydobacteriaYes43**Dictyoglomididerm Gram−No2Elusimicrobiadiderm Gram−No3**Firmicutesmonoderm low G + C Gram+: *Bacillus, Clostridium*Yes1149**Fusobacteriadiderm Gram−No25Gemmatimonadetesdiderm Gram−No5Lentisphaeraediderm Gram−No2Nitrospiraediderm Gram−No10Planctomycetesdiderm Gram−: planctobacteriaNo22**Proteobacteria-αdiderm Gram−: *Rickettsia, Rhizobium*Yes678**Proteobacteria-βdiderm Gram−: *Bordetella*, *Neisseria*No350Proteobacteria-γdiderm Gram−: *Escherichia, Pseudomonas*No982**Proteobacteria-δdiderm Gram−: *Desulfovibrio, Geobacter*Yes142**Proteobacteria-εdiderm Gram−: *Helicobacter*No78**Spirochaetesdi-derm Gram−: *Borrelia, Treponema*Yes81**Synergistetesdiderm Gram−No18TenericutesMonoderm: *Mycoplasma*No132**Thermodesulfobacteriadiderm Gram−: glidobacteriaYes3**Thermotogaediderm Gram−No26Verrucomicrobiadiderm Gram−No37[^1][^2][^3][^4]

Crystal structures of *Tth* ([@bib44]) and *Mtb* ([@bib20]) CarD reveal an N-terminal domain with a Tudor-like fold (CarD-RID, RNAP interacting domain) in common with the *Eco* transcription repair coupling factor (TRCF)-RID ([@bib10]; [@bib45]; [@bib48]), and a helical C-terminal domain (CarD-CTD). Unique among known transcription activators, the CarD-RID interacts with the RNAP β subunit β1-lobe ([@bib45]; [@bib48]) (corresponding to the eukaryotic RNAP II Rpb2 protrusion domain; [@bib8]), which is near the upstream portion of the transcription bubble in RPo ([@bib5]). The disposition of the CarD-CTD with respect to the CarD-RID is widely divergent in *Tth* and *Mtb* CarD crystal structures, leading to conflicting models for the CarD activation mechanism ([@bib20]; [@bib44]). To resolve these ambiguities, we determined crystal structures of *Thermus aquaticus* (*Taq*) transcription initiation complexes (RPo) ([@bib5]) containing CarD ([Figure 1A,B](#fig1){ref-type="fig"}). The structures show that CarD interacts with the unique DNA topology of the upstream double-stranded/single-stranded (ds/ss) DNA junction of the transcription bubble. Additional biochemical data confirm that our structures correspond to functional activation complexes, and extend our understanding of the role of a universally conserved CarD Trp residue in stabilizing the unwound transcription bubble, thereby stabilizing the transcription initiation complex.10.7554/eLife.08505.004Figure 1.Structure of the Thermus CarD/RPo complex.(**A**) Synthetic oligonucleotides used for CarD/RPo crystallization. The numbers above denote the DNA position with respect to the transcription start site (+1). The DNA sequence is derived from the full con promoter ([@bib17]). The −35 and −10 (Pribnow box) elements are shaded yellow, the extended −10 ([@bib27]) and discriminator ([@bib15]; [@bib23]) elements purple. The nt-strand DNA (top strand) is colored dark grey; the t-strand DNA (bottom strand), light grey; the RNA transcript, red. The colored blocks denote protein/nucleic acid interactions: σ^A^, orange; β, cyan; β′, pink; CarD, green. CarD interacts exclusively at the upstream junction of the transcription bubble. (**B**) Overall structure of CarD/RPo---two orthogonal views. The nucleic acids are shown as CPK atoms and color-coded as above. Proteins are shown as molecular surfaces. The RNA polymerase (RNAP) holoenzyme is color coded as follows: αI, αII, ω, grey; β′, light pink; Δ1.1σ^A^, light orange; β is light cyan except the β1-lobe (interacting with the CarD-RID, corresponding to RNAP β subunit residues 18--138 and 333--392) is light blue. The CarD-RID is magenta, CarD-CTD green. In the right view, the boxed region is magnified in (**C**). (**C**) Magnified view illustrating the CarD-RID/β1-lobe protein/protein interaction and CarD-CTD (α3 and α5)/DNA interactions at the upstream ds(−12)/ss(−11) junction of the transcription bubble. (**D**) CarD does not alter the transcription bubble. KMnO~4~ footprints (t-strand) of Thermus RNAP holoenzyme on the *Mtb* AP3 promoter. (*Top*) Sequence of the AP3 promoter ([@bib22]). T-strand thymidines rendered KmnO~4~ reactive by RNAP are denoted (red arrows). (*Bottom*) KMnO~4~ footprints. Lane 1, no protein added; lanes 2--3, RNAP holoenzyme − or + CarD (respectively); lanes 4--7, the effect of incubating with a competitor promoter trap for the indicated amounts of time.**DOI:** [http://dx.doi.org/10.7554/eLife.08505.004](10.7554/eLife.08505.004)10.7554/eLife.08505.005Figure 1---figure supplement 1.Sequences of *Mtb rrnA*AP3 ([@bib19]) and *Tth* 23S ribosomal RNA (rRNA) ([@bib22]), promoters used in in vitro assays, and full con ([@bib17]) used for structural studies.**DOI:** [http://dx.doi.org/10.7554/eLife.08505.005](10.7554/eLife.08505.005)10.7554/eLife.08505.006Figure 1---figure supplement 2.Crystal packing interactions in CarD/RPo P4~3~2~1~2 crystals.One asymmetric unit of the crystals contains two CarD/RPo complexes, complex A \[RNAP(A), cyan; CarD(A), blue\] and complex B \[RNAP(B), pink; CarD(B), red\]. One central asymmetric unit is shown (proteins as molecular surfaces), with neighboring symmetry-related complexes shown as ribbons; only symmetry-related complexes that make crystal packing contacts with the central asymmetric unit are shown. CarD(A) makes a crystal packing contact with a symmetry-related CarD(A) (circled in red), but CarD(B) is not involved in any crystal packing interactions. Nevertheless, the protein/protein and protein/DNA contacts in complex(A) and complex(B) are essentially identical.**DOI:** [http://dx.doi.org/10.7554/eLife.08505.006](10.7554/eLife.08505.006)10.7554/eLife.08505.007Figure 1---figure supplement 3.CarD/β1-lobe structure.(*Top*) View of the CarD/RPo structure, similar to [Figure 1B](#fig1){ref-type="fig"} (*Right*) except the RNAP β1-lobe and CarD are shown as backbone ribbons without surfaces. (*Bottom*) The CarD/β1-lobe structure (2.4 Å-resolution, [Table 1](#tbl1){ref-type="table"}) shown in the orientation corresponding to the *top* view.**DOI:** [http://dx.doi.org/10.7554/eLife.08505.007](10.7554/eLife.08505.007)10.7554/eLife.08505.008Figure 1---figure supplement 4.Slight movement of CarD-CTD towards DNA when DNA is present.CarD/us-fork and CarD/RPo structures (four copies, two crystallographically independent copies from each structure) are shown superimposed by the Cα positions in the β1-lobe. In all these structures in the presence of promoter DNA, the β1-lobe is colored cyan, CarD is colored dark red, and CarD-W86 is shown in CPK format. The CarD/β1-lobe structure is also superimposed by the Cα positions of the β1-lobe (slate blue), with the CarD-RID magenta and the CarD-CTD green. Viewing the structures superimposed this way reveals a rotation of the CarD-CTD of ∼11° towards the DNA (when promoter DNA is present).**DOI:** [http://dx.doi.org/10.7554/eLife.08505.008](10.7554/eLife.08505.008)10.7554/eLife.08505.009Figure 1---figure supplement 5.Data and model quality.Plots relating data quality with model quality using the Pearson correlation coefficient (CC) analysis described by [@bib26]. CC1/2 (red squares) was determined from the unmerged diffraction data randomly divided in half. Since CC1/2 underestimates the information content of the data (since it\'s calculated by dividing the dataset in half), CC\* was calculated from an analytical relation to estimate the information content of the full data ([@bib26]). CC\* provides a statistic that assesses data quality as well and also allows direct comparison of crystallographic model quality and data quality on the same scale through CC~work~ and CC~free~, the standard and cross-validated correlations of the experimental intensities with the intensities calculated from the refined model. A CC~work~/CC~free~ smaller than CC\* indicates that the model does not account for all of the signal in the data, meaning it is not overfit. Plotted also are the standard \<*I*\>/σ*I* for the diffraction data, as well as the *R*~work~/*R*~free~ for the refined models. (*Left*) Data for *Tth* CarD/*Taq* EΔ1.1σ^A^/us-fork (−12 bp) at 4.4 Å-resolution. (*Right*) Data for *Tth* CarD/*Taq* EΔ1.1σ^A^ RPo (with 4-nt RNA primer) at 4.3 Å-resolution.**DOI:** [http://dx.doi.org/10.7554/eLife.08505.009](10.7554/eLife.08505.009)10.7554/eLife.08505.010Figure 1---figure supplement 6.CarD does not alter the structure of the transcription bubble.Superimposition of the nucleic acids from the CarD/RPo (colored as in [Figure 1A](#fig1){ref-type="fig"}) and RPo (magenta) ([@bib5]) structures. The only significant differences occur in the single-stranded t-strand from −11 to −7; this part of the DNA is relatively unconstrained by protein/DNA interactions and has very high B-factors.**DOI:** [http://dx.doi.org/10.7554/eLife.08505.010](10.7554/eLife.08505.010)

Throughout this work, we use three promoter sequences, full con ([@bib17]), *Tth* 23S ([@bib22]), and *Mtb* AP3 ([@bib19]) ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). The full con promoter sequence, derived by in vitro evolution, is likely to be optimized for binding to Eσ^A^. We use this sequence only for structural studies where high-affinity, homogeneous complexes are critical for crystallization. AP3 is a native *Mtb* rRNA promoter and its regulation by *Mtb* CarD has been well characterized ([@bib44]; [@bib9]). In order to biochemically characterize more than one promoter, we also studied 23S, a native *Tth* rRNA promoter. In promoter-based assays, the effects of *Tth* or *Mtb* CarD on each promoter were qualitatively the same. In general, we present the results from *Tth* 23S since most of the studies used *Thermus* Eσ^A^ and CarD. In some cases, it was advantageous to use *Mtb* AP3 instead and we note the rationales below.

Results {#s2}
=======

Overall structure of the *Thermus* CarD/RPo complex {#s2-1}
---------------------------------------------------

Crystals of CarD transcription activation complexes were prepared by soaking *Tth* CarD into *Taq* Δ1.1σ^A^-holoenzyme/us-fork (−12 bp) or full RPo crystals ([@bib5]). Analysis of the diffraction data indicated high occupancy of one CarD molecule bound to each of two RNAP/promoter complexes in the asymmetric unit of the crystal lattice ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Docking CarD onto the RNAP was facilitated by a high-resolution crystal structure of a *Tth* CarD/*Taq* β1-lobe complex (2.4 Å-resolution, [Table 2](#tbl2){ref-type="table"}, [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}, [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). The structures of CarD transcription activation complexes were refined to 4.4 and 4.3 Å-resolution, respectively ([Table 2](#tbl2){ref-type="table"}, [Figure 1---figure supplement 5](#fig1s5){ref-type="fig"}). The protein/protein and protein/nucleic acid interactions were essentially identical among all of the four crystallographically independent complexes, so the more complete and higher resolution CarD/RPo structure ([Figure 1A,B](#fig1){ref-type="fig"}, [Figure 1---figure supplement 5](#fig1s5){ref-type="fig"}, [Table 2](#tbl2){ref-type="table"}) is described here. Although the CarD bound to one RPo in the crystallographic asymmetric unit made crystal-packing interactions with a symmetry-related CarD, the CarD bound to the second RPo did not participate in any crystal-packing interactions ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}), indicating the architecture and interactions observed here are unlikely to be influenced by crystal packing interactions and likely represent the functional activation complex in solution.10.7554/eLife.08505.011Table 2.Crystallographic statistics**DOI:** [http://dx.doi.org/10.7554/eLife.08505.011](10.7554/eLife.08505.011)Holo-bubble-CarDHolo-fork-CarDCarD/β1-lobeData collection Space groupP4~3~2~1~2P4~3~2~1~2I4 Combined datasets461 Cell dimensions  *a* (Å)289.84293.15149.32  *b* (Å)289.84293.15149.32  *c* (Å)536.34539.1352.26 Wavelength (Å)1.0751.0751.1 Resolution (Å)39.56--4.3 (4.45--4.3)[†](#tblfn4){ref-type="table-fn"}49.61--4.40 (4.56--4.40)[†](#tblfn4){ref-type="table-fn"}49.32--2.40 (2.49--2.40)[†](#tblfn4){ref-type="table-fn"} Total reflections1,204,932 (93,381)2,004,840 (73,134)138,950 (13,077) Unique reflections153,939 (12,740)148,420 (10,172)22,705 (2257) Multiplicity7.8 (6.2)13.5 (5.0)6.1 (5.8) Completeness (%)99.6 (99.2)99.9 (99.6)100% (100%) \<*I*\>/σ*I*5.06 (0.65)9.10 (0.41)19.13 (1.66) Wilson B-factor165.15151.3349.38 *R*~pim~[‡](#tblfn5){ref-type="table-fn"}0.295 (1.61)0.138 (2.03)0.033 (0.44) CC1/2[§](#tblfn6){ref-type="table-fn"}0.948 (0.114)0.971 (0.166)0.998 (0.49) CC\*[§](#tblfn6){ref-type="table-fn"}0.987 (0.453)0.993 (0.534)1.00 (0.811)Twinning operator----−k, −h, −l fraction----0.42Anisotropic scaling B-factors[\#](#tblfn7){ref-type="table-fn"} *a\*, b\** (Å^2^)16.9516.01-- *c\** (Å^2^)−33.90−32.03--Refinement *R*~work~/*R*~free~0.2748/0.3094 (0.3916/0.4100)0.2198/0.2639 (0.3660/0.3920)0.1629/0.1863 (0.2582/0.3036) CC~work~/CC~free~[§](#tblfn6){ref-type="table-fn"}0.928/0.890 (0.261/0.267)0.921/0.891 (0.318/0.262)0.870/0.498 (0.498/0.437) No. atoms60,87858,9902753  Protein/DNA60,87258,9842657  Ligand/ion6620  Water0076 Protein residues71977195342 *B*-factors  Protein179.52194.6660.35  Ligand/ion158.99139.4849.77  Water----52.81 R.m.s deviations  Bond lengths (Å)0.0050.0040.010  Bond angles (°)0.961.011.35 Clashscore19.5814.8319.72 Ramachandran favored (%)888991 Ramachandran outliers (%)0.480.570.89[^5][^6][^7][^8]

The CarD-CTD interacts with the upstream ds/ss junction of the transcription bubble {#s2-2}
-----------------------------------------------------------------------------------

The relative orientation of the CarD domains (CarD-RID, CarD-CTD) seen in the *Thermus* CarD ([@bib44]) and CarD/β1-lobe ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}) structures is only slightly altered in the *Thermus* CarD/RPo complex: the CarD-CTD is rotated ∼11° (with respect to the CarD-RID) to interact with the DNA ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). By maintaining the CarD-RID/CTD interface seen in all the *Tth* CarD structures, binding of the CarD-RID to the RNAP β1-lobe ([Figure 1B,C](#fig1){ref-type="fig"}, [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}) ([@bib45]; [@bib48]; [@bib20]) positions the CarD-CTD to interact directly with the upstream ds/ss junction of the transcription bubble ([Figure 1A--C](#fig1){ref-type="fig"}).

In the RPo structure, the $\text{σ}_{2}^{\text{A}}$ and $\text{σ}_{3}^{\text{A}}$ domains make extensive interactions with the promoter DNA (−17 to −4) from the (distorted) major groove side of the DNA, including critical interactions that maintain the upstream ds(−12)/ss(−11) junction of the transcription bubble ([Figure 1A--C](#fig1){ref-type="fig"}) ([@bib5]). CarD does not make significant interactions with σ^A^ but interacts with the promoter DNA from −14 to −10 from the opposite, (distorted) minor groove side of the DNA ([Figure 1A--C](#fig1){ref-type="fig"}) such that the σ^A^/DNA interactions and the structure of the transcription bubble in RPo and CarD/RPo are essentially the same ([Figure 1---figure supplement 6](#fig1s6){ref-type="fig"}). The KMnO~4~ reactivity of thymine (T) bases within the transcription bubble ([@bib41]; [@bib39]) is identical in the presence or absence of CarD ([Figure 1D](#fig1){ref-type="fig"}, lanes 2 and 3), supporting the structural observation that the transcription bubble is the same with or without CarD. Although CarD does not alter the structure of the transcription bubble, it does increase the lifetime of RPo, as measured by the rate of disappearance of the KMnO~4~ footprint after challenge with an excess of unlabeled competitor promoter ([Figure 1D](#fig1){ref-type="fig"}, lanes 4--7) ([@bib9]).

The N-terminal ends of two CarD-CTD α-helices (α3 and α5) make direct contacts with the promoter DNA ([Figure 1C](#fig1){ref-type="fig"}, [Figure 2](#fig2){ref-type="fig"}). The two α-helices are positioned roughly perpendicular to the duplex DNA axis, forming a modest CarD/DNA interaction surface of 380 Å^2^.10.7554/eLife.08505.012Figure 2.CarD-CTD/promoter DNA interactions.(**A**) Stereo view of the refined, B-factor sharpened (−80 Å^2^) 2*F*~o~ − *F*~c~ map (grey mesh, contoured at 1σ), with superimposed DNA and CarD. Density for the close approach of the CarD peptide backbone to the −14(t) DNA phosphate backbone and for CarD-W86 are clearly resolved. (**B**) Close up view showing interactions between the N-terminal ends of α3 and α5 of the CarD-CTD with promoter DNA at the upstream ds(−12)/ss(−11) junction of the transcription bubble. Grey dashed lines indicate potential polar interactions between the peptide backbone nitrogen of L124 and the −14(t) phosphate oxygen, and W86 Nε and O2 of T~−12~(nt). (**C**) Same view as [Figure 2B](#fig2){ref-type="fig"}. Superimposed is the simulated annealing omit map (dark green mesh, *F*~o~ − *F*~c~, contoured at 3σ), calculated from a model where CarD-W86 was mutated to Ala. The unbiased difference Fourier density shows that the side chain position is specified in the data.**DOI:** [http://dx.doi.org/10.7554/eLife.08505.012](10.7554/eLife.08505.012)10.7554/eLife.08505.013Figure 2---figure supplement 1.Alignment of CarD homologs found in bacteria from 11 diverse phyla/groups.The CarD sequences shown are from the following organisms chosen to represent the preceding phylum/group: Deinococcus--Thermus-*Tth* HB8, Actinobacteria--*Mtb,* Acidobacteria--*Candidatus Solibacter usitatus,* α-Proteobacteria--*Rickettsia belli*, Aquificae--*Desulfurobacterium thermolithotrophum*, Chlamydae--*Chlamydae trachomatis,* Cyanobacteria--*Mastigocoleus testarum,* δ*-*Proteobacteria--*Desulfobulbus propionicus*, Firmicutes--*Bacillus cereus,* Spirochaetes--*Treponema pallidum* and Thermodesulfobacteria--*Thermodesulfatator atlanticus*. Alignments were performed using the ClustalW algorithm in MegAlign (DNASTAR). Groups of residues considered homologous (DE), (HKR), (ALMIV), (NQ), (ST), (C), (G) and (P) are shaded blue when occurring in greater than 9/11 sequences. Identical residues occurring in all 11 sequences are shaded black. Histograms above the alignment graphically illustrate residues that are absolutely conserved within each of the 11 sequences and W86 is asterisked. The 100% identical residue is listed immediately below the histogram. A larger alignment of 831 CarD sequences is included ([Source code 1](#SD1-data){ref-type="supplementary-material"}).**DOI:** [http://dx.doi.org/10.7554/eLife.08505.013](10.7554/eLife.08505.013)

The peptide backbone nitrogen of CarD-L124, at the N-terminal end of α5, closely approaches the backbone phosphate oxygen of the template strand (t-strand) at the −14 position \[−14(t)\] ([Figure 2](#fig2){ref-type="fig"}), possibly forming a hydrogen bond, an interaction likely facilitated by the partial positive charge of the α5 helix dipole ([@bib24]). Similar interactions have been observed in other DNA-binding proteins, such as helix-turn-helix proteins ([@bib21]) and the nucleosome core particle ([@bib31]).

Role of a conserved CarD Trp residue in CarD function {#s2-3}
-----------------------------------------------------

W86 is conserved among greater than 95% of CarD proteins ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}; [Source code 1](#SD1-data){ref-type="supplementary-material"}) and was shown to be important for CarD function as an activator ([@bib44]). The bulky, hydrophobic planar side chain of W86, located at the N-terminal end of α3, wedges into the splayed minor groove at the upstream edge of the transcription bubble ([Figure 2](#fig2){ref-type="fig"}). Despite the relatively low resolution of our analysis ([Table 2](#tbl2){ref-type="table"}), CarD-W86 was clearly resolved in electron density maps ([Figure 2A](#fig2){ref-type="fig"}). The positioning of CarD-W86 was further supported by an unbiased simulated annealing omit *F*~o~ − *F*~c~ map calculated from coordinates in which CarD-W86 had been mutated to Ala ([Figure 2C](#fig2){ref-type="fig"}).

Previous work showed that substitution of the bulky CarD-W86 side chain by Ala (*Tth* CarD-W86A or *Mtb* CarD-W85A) greatly reduced the activation efficiency of both *Tth* and *Mtb* CarD ([@bib44]). To further evaluate the role of W86 in CarD function, we tested the activation efficiency of CarD harboring substitutions of W86 to other hydrophobic residues (A, F, Y, L, I and V) in an in vitro abortive transcription assay on the *Tth* 23S promoter ([Figure 3A](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). All of the mutants tested showed impaired activity compared to wild-type CarD. A, F, and Y substitutions showed partial activation, while substitutions with branched-chain residues (I, L, V) showed no activation (I, V) or even a reduction of transcription compared to wild type CarD (L). Structural modeling suggests the branched-chain residues would clash with the DNA and interfere with CarD function.10.7554/eLife.08505.014Figure 3.Function of CarD-W86.(**A**) The effect of CarD-W86 substitutions on activation of abortive initiation (UpG dinucleotide + α-^32^P-CTP) on the *Tth rrnA-23S* promoter (normalized with respect to no CarD). Error bars denote the standard error from a minimum of three experiments. (**B**) The effect of promoter −12 base pair substitutions on activation of abortive initiation (GpU dinucleotide + α-^32^P-UTP) by CarD on the *Mtb rrnA-*AP3 promoter. Error bars denote standard errors.**DOI:** [http://dx.doi.org/10.7554/eLife.08505.014](10.7554/eLife.08505.014)10.7554/eLife.08505.015Figure 3---figure supplement 1.Complete gels for the abortive initiation assays shown in (**A**) [Figure 3A](#fig3){ref-type="fig"} and (**B**) [Figure 3B](#fig3){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.08505.015](10.7554/eLife.08505.015)

The position of the W86 side chain Nε allows it to interact with T~−12~(nt) O2 ([Figure 2B](#fig2){ref-type="fig"}). Since this mode of Trp/Thymine interaction is not common among DNA-binding proteins ([@bib29]), we mutated the promoter −12 T/A base pair to C/G, G/C and A/T, and compared CarD activation at each of the three mutant promoters with its effect at the wild type promoter (we used *Mtb* AP3 for this analysis since *Tth* Eσ^A^ was more active on this promoter than on *Tth* 23S, allowing us to analyze the weak activity of the mutant promoters). The −12 T/A base pair is a conserved part of the promoter −10 element ([@bib43]), and, as expected, transcription activity from each of the mutant promoters was reduced at least threefold ([Figure 3B](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) ([@bib34]). In addition, CarD activation on each mutated promoter was substantially lower than on the wild type promoter ([Figure 3B](#fig3){ref-type="fig"}), suggesting that the observed interaction between W86 and T~−12~(nt) contributes to CarD activity.

Note that the CarD W86F substitution results in an approximately twofold loss in CarD fold activation ([Figure 3A](#fig3){ref-type="fig"}, threefold activation for wild-type CarD vs 1.5-fold for W86F), as does substitution of the promoter −12 bp by anything other than the wild-type T/A bp ([Figure 3B](#fig3){ref-type="fig"}). The Phe side chain at CarD position 86 would be expected to fulfill the stacking and steric roles of CarD-W86 effectively, but would not be able to participate in the putative H-bond with the T~−12~(nt) O2 atom. We tentatively suggest that the reduced activation efficiency of the CarD-W86F mutant is primarily due to the loss of the minor groove polar interaction with T~−12~(nt).

The *Thermus* CarD/RNAP initiation complex structures represent the active conformation of CarD {#s2-4}
-----------------------------------------------------------------------------------------------

A crystal structure of *Mtb* CarD in complex with an *Mtb* RNAP β-subunit fragment that includes the β1-lobe shows a relative orientation of the CarD-RID/CarD-CTD domains very different from the one in our *Tth* CarD structures, despite high sequence and structural similarity within the domains ([@bib20]; [@bib44]). In the *Mtb* structure, the CarD-CTD is rotated ∼140° relative to the CarD-RID ([Figure 4A](#fig4){ref-type="fig"}). Structural modeling in the context of RPo positions the *Mtb* CarD-CTD and the functionally important W85 away from the promoter DNA ([Figure 4A,B](#fig4){ref-type="fig"}). To determine the functional conformation of CarD, we introduced a disulfide to lock the conformation of *Mtb* CarD into the one observed in the *Tth* CarD structures. In the seven crystallographically independent copies of *Tth* CarD (PDB IDs 4L5G and structures reported here) ([@bib44]), the average distance between the α-carbons of CarD-RID-P13 and CarD-CTD-G100 is 5.7 ± 0.8 Å, and among the four copies determined in the presence of promoter DNA, an even tighter distribution is observed, 5.2 ± 0.1 Å ([Figure 4B](#fig4){ref-type="fig"}, *right*). On the other hand, the corresponding positions in the *Mtb* CarD structure (P12/G99) are 24 Å apart ([Figure 4B](#fig4){ref-type="fig"}, *left*) ([@bib20]). Cys substitions at these positions are predicted to form a disulfide bond under oxidizing conditions in the *Tth* CarD conformation (thus locking the domain orientation), but not the *Mtb* CarD conformation ([Figure 4B](#fig4){ref-type="fig"}). We engineered the P12/G99 Cys substitutions in *Mtb* CarD (*Mtb* CarD2C; wild-type *Mtb* CarD is devoid of Cys residues). Non-reducing SDS polyacrylamide gel electrophoresis and liquid chromatography mass spectrometry confirmed that under oxidizing conditions, the CarD-RID and CarD-CTD were disulfide crosslinked in greater than 98% of CarD2C, while under reducing conditions, no disulfide bond was present in \>99% of CarD2C ([Figure 4C](#fig4){ref-type="fig"}). We tested the function of oxidized (crosslinked) and reduced CarD2C using a mycobacterial transcription system ([@bib44]; [@bib9]) on the *Mtb* AP3 promoter. Under oxidizing conditions, the cross-linked, conformationally locked CarD2C activated transcription as well as wild type CarD ([Figure 4D](#fig4){ref-type="fig"}, 0 mM dithiothreitol \[DTT\], [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). The observation that under reducing conditions, CarD2C was somewhat impaired in transcription activation ([Figures 4D, 5](#fig4 fig5){ref-type="fig"} mM DTT) is explained by the fact that the CarD positions corresponding to *Mtb* CarD P13 and G99 are conserved ([@bib44]; [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}, [Source code 1](#SD1-data){ref-type="supplementary-material"}); on this basis substitution of these positions would be expected to impair uncrosslinked CarD2C function. We conclude that the *Tth* CarD structures, with CarD-CTD W86 positioned to interact with the upstream edge of the transcription bubble ([Figure 2](#fig2){ref-type="fig"}), represents the functional conformation of CarD.10.7554/eLife.08505.016Figure 4.Inter-domain crosslinking confirms the functional conformation of CarD.(**A**) View of the Thermus CarD/RPo complex. RNAP holoenzyme and nucleic acids are shown as in [Figure 1B](#fig1){ref-type="fig"}; *Tth* CarD is shown as an α-carbon ribbon (*Tth* CarD-RID, magenta; *Tth* CarD-CTD, green) but with W86 shown in CPK format and colored dark green. Also shown is *Mtb* CarD from the *Mtb* CarD/β1-β2-lobe structure (4KBM; *Mtb* CarD-RID, dark red; *Mtb* CarD-CTD, brown, but with W85 colored dark brown), superimposed by alignment of 145 Cα atoms from the β1-lobe (1.39 Å rmsd). The boxed region is magnified in (**B**). (**B**) (*Left*) Magnified view showing the modeled *Mtb* CarD in the context of RPo. The α-carbons of CarD-RID-P12 and CarD-CTD-G99, shown as red spheres, are ∼24 Å apart (red dashed line). A disulfide bond between these two positions in *Mtb* CarD2C (P12C/G99C substitutions) would disallow this conformation of CarD. (*Right*) Magnified view of the Thermus CarD/RPo complex. CarD-RID-P13 and CarD-CTD-G100 are ∼5.2 Å apart (red dashed line). A disulfide bond between the corresponding two positions in *Mtb* CarD2C would lock this DNA-interacting conformation of CarD. (**C**) Purification of disulfide crosslinked (lanes 5, 6) and reduced (lanes 7, 8) CarD2C. Non-reducing SDS-PAGE illustrates that CarD2C is oxidized (crosslinked) in the absence of reducing agent dithiothreitol (DTT) and is reduced (uncrosslinked) in the presence of DTT. Samples were excised from gels and LC-MS was used to confirm oxidation states. (**D**) Effect of oxidation state on *Mtb* CarD2C activation of abortive transcription on the *Mtb* AP3 promoter (GpU dinucleotide + α-^32^P-UTP). Conformationally locked (no DTT) *Mtb* CarD2C exhibits wild type activation activity.**DOI:** [http://dx.doi.org/10.7554/eLife.08505.016](10.7554/eLife.08505.016)10.7554/eLife.08505.017Figure 4---figure supplement 1.Complete gel for the abortive initiation assay shown in [Figure 4D](#fig4){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.08505.017](10.7554/eLife.08505.017)10.7554/eLife.08505.018Figure 5.CarD increases the lifetime of Thermus RPo.(**A**) Sequences of *Mtb rrnA*AP3 ([@bib19]) and *Tth* 23S rRNA ([@bib22]) promoters used in in vitro assays. (**B**, **C**) Lifetimes of promoter complexes measured by abortive transcription. At the top of each panel, \[^32^P\]-labeled abortive transcript production at times after addition of a large excess of competitor promoter DNA trap was monitored by polyacrylamide gel electrophoresis and autoradiography. On the bottom, transcript production was quantified by phosphorimagery and plotted. The lines indicate single-exponential decay curves fit to the data points. The calculated decay half-lives (*t*~1/2~) are shown to the right of the gel images. Assays were performed on the following templates: (**B**) *Tth rrnA-23S* promoter (UpG dinucleotide + α-^32^P-CTP). (**C**) *Mtb rrnA-*AP3 promoter (GpU dinucleotide + α-^32^P-UTP).**DOI:** [http://dx.doi.org/10.7554/eLife.08505.018](10.7554/eLife.08505.018)10.7554/eLife.08505.019Figure 5---figure supplement 1.Complete gels for the abortive initiation assays shown in [Figure 5B](#fig5){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.08505.019](10.7554/eLife.08505.019)10.7554/eLife.08505.020Figure 5---figure supplement 2.Complete gels for the abortive initiation assays shown in [Figure 5C](#fig5){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.08505.020](10.7554/eLife.08505.020)

CarD stabilizes RPo by preventing transcription bubble collapse {#s2-5}
---------------------------------------------------------------

CarD may stabilize RPo by forming favorable interactions with the upstream edge of the unwound transcription bubble ([Figures 1C, 2B](#fig1 fig2){ref-type="fig"}). We tested the lifetime of competitor-resistant RPo challenged with a competitive promoter trap ([@bib9]) using the abortive initiation assay on both the 23S and AP3 promoters ([Figure 5A](#fig5){ref-type="fig"}). *Tth* CarD increased the half-life (*t*~1/2~) of the *Thermus* RPo ∼threefold on each promoter ([Figure 5B](#fig5){ref-type="fig"}, [Figure 5C](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}, [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}) while *Eco* RNAP did not dissociate significantly from either promoter over the lifetime of the experiments (*t*~1/2~ \>\> 120 min; [Figure 5B](#fig5){ref-type="fig"}) ([@bib9]). The *Tth* CarD W86A substitution diminished or abolished the ability of CarD to increase *t*~1/2~ on the 23S and AP3 promoter, respectively ([Figure 5B,C](#fig5){ref-type="fig"}).

Clearly, dissociation of RPo and transcription bubble collapse (rewinding) are closely linked. We hypothesized that CarD may increase the lifetime of RPo by preventing transcription bubble collapse. To test this hypothesis, we determined the effect of CarD on the lifetime of promoter complexes on a synthetic promoter template based on the 23S sequence and compared it with the same synthetic template but with a non-complementary transcription bubble (from −11 to +2) unable to collapse ([Figure 6A](#fig6){ref-type="fig"}). On the duplex template (23S_DS), CarD increased the *t*~1/2~ more than fivefold ([Figure 6B](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). On the bubble template ([Figure 6A](#fig6){ref-type="fig"}, 23S_Bub) in the absence of CarD, the *t*~1/2~ was also increased more than fivefold, indicating that the relatively short lifetime of *Tth* RPo on the 23S promoter is due largely to bubble collapse ([Figure 6B](#fig6){ref-type="fig"}). Addition of CarD to the bubble template had no effect on the level of transcription and did not affect RPo lifetime ([Figure 6B](#fig6){ref-type="fig"}). We thus conclude that a primary function of *Tth* CarD, like *Mtb* CarD ([@bib9]), is to stabilize RPo by preventing collapse of the transcription bubble.10.7554/eLife.08505.021Figure 6.CarD increases the lifetime of Thermus RPo by preventing transcription bubble collapse.(**A**) Synthetic duplex (23S_DS) and artificial bubble (23S_Bub) promoters used in in vitro assays. (**B**) Lifetimes of promoter complexes formed on synthetic templates measured by abortive transcription (UpG dinucleotide + α-^32^P-UTP). (*Left*) \[^32^P\]-labeled abortive transcript production at times after addition of a large excess of competitor promoter DNA trap was monitored by polyacrylamide gel electrophoresis and autoradiography. (*Right*) transcript production was quantified by phosphorimagery and plotted. The lines indicate single-exponential decay curves fit to the data points. The calculated decay half-lives (*t*~1/2~) are shown to the right of the gel images. Assays were performed on the synthetic double-stranded (23S_DS) and bubble (23S_Bub) templates.**DOI:** [http://dx.doi.org/10.7554/eLife.08505.021](10.7554/eLife.08505.021)10.7554/eLife.08505.022Figure 6---figure supplement 1.Complete gels for the abortive initiation assays shown in [Figure 6B](#fig6){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.08505.022](10.7554/eLife.08505.022)

Discussion {#s3}
==========

CarD is an essential transcription activator in *Mtb* that is also widely distributed among bacterial species, including *Thermus* species but not found in *Eco* ([@bib45]; [@bib44]; [Table 1](#tbl1){ref-type="table"}). In the absence of a structure of a mycobacterial transcription initiation complex, we present here the structure of *Tth* CarD with a *Taq* transcription initiaton complex ([Figure 1B](#fig1){ref-type="fig"}). The structural results, combined with supporting biochemical studies, establish that the CarD-RID makes a protein/protein interaction with the RNAP β1-lobe, thereby positioning the CarD-CTD and a conserved Trp residue to interact with the upstream edge of the transcription bubble, using a wedge mechanism to prevent collapse of the transcription bubble ([Figures 1C, 2B](#fig1 fig2){ref-type="fig"}). This is a previously unseen mechanism of activation by a transcription factor. Specifically: (1) CarD does not induce any major changes on the holoenzyme nor the transcription bubble ([Figure 1D](#fig1){ref-type="fig"}); (2) CarD contacts with the DNA are mostly confined to the backbone phosphates, with the exception of the conserved Trp (W86) that serves as a wedge at the upstream edge of the bubble, which may be stabilized by a hydrogen bond with the conserved T~−12~(t) ([Figure 2B](#fig2){ref-type="fig"}). We show that this W-wedge residue and its interaction with T~−12~(t) is important for full CarD function ([Figure 3](#fig3){ref-type="fig"}); (3) We show that *Tth* CarD functions similarly to *Mtb* CarD to increase the lifetime of RPo by preventing collapse of the transcription bubble ([Figure 5](#fig5){ref-type="fig"}, [Figure 6](#fig6){ref-type="fig"}); (4) We show that the mode of CarD interaction with RNAP and with the promoter DNA revealed by our structures represents the functionally relevant conformation ([Figure 4](#fig4){ref-type="fig"}), resolving conflicting models.

*Eco* has served as a model organism for the study of many cellular processes over the last few decades, including transcription. *Eco* RNAP forms unusually stable RPo and *Eco* lacks CarD, while RNAPs shown to form relatively unstable RPo come from bacteria that harbor CarD (*Bacillus subtilis*, [@bib49]; [@bib2]; *Mtb*, [@bib9]; *Myxococcus xanthus*, [@bib18]; *Taq*, [@bib33]; *Tth*, [@bib50]). Moreover, CarD is a global regulator, found at most σ^A^ promoters throughout the *Mycobacterium smegmatis* genome ([@bib44]), and is essential in the two mycobacterial species where it has been tested ([@bib45]). These observations suggest that CarD boosts transcription at most (if not all) promoters by acting as a basal transcription factor, required to compensate for otherwise rapidly dissociating RNAP/promoter complexes. While the interaction with T~−12~(t) ([Figure 2B](#fig2){ref-type="fig"}, [Figure 3B](#fig3){ref-type="fig"}) may modulate the effect of CarD in a promoter-specific manner, this is likely to be a minor effect in vivo since T~−12~(t) is present at most σ^A^ promoters ([@bib43]), and CarD can nevertheless activate transcription from promoters that lack a −12 T/A base pair (although less effectively; [Figure 3B](#fig3){ref-type="fig"}).

The structural and biochemical studies of *Tth* CarD/RPo complexes presented here reveal how the widely distributed transcription factor CarD interacts with RPo to activate initiation. The CarD-RID/RNAP β1-lobe protein/protein interaction positions the CarD-CTD to interact with the upstream edge of the transcription bubble in a functionally relevant pose that does not allosterically alter the structure of the transcription bubble nor RNAP holoenzyme/promoter interactions ([Figure 1D](#fig1){ref-type="fig"}, [Figure 1---figure supplement 6](#fig1s6){ref-type="fig"}); instead CarD supports pre-existing RNAP holoenzyme/promoter DNA interactions in RPo. The mode of CarD/DNA interaction is incompatible with duplex B-form DNA; the normal minor groove is too narrow to accommodate the end of CarD-α3 and CarD-W86 ([@bib44]). This is consistent with a kinetic analysis of CarD function that concluded CarD stabilizes RPo by increasing the rate of isomerization to RPo and decreasing the rate of bubble collapse, but has little effect on the formation of the closed RNAP/promoter complex ([@bib38]).

The CarD contacts with the DNA occur mostly through the backbone phosphates, except for highly conserved CarD-W86, which wedges between the splayed DNA strands at the upstream edge of the transcription bubble and may form a hydrogen bond with T~−12~(t) O2 presented in the highly distorted minor groove ([Figure 2B](#fig2){ref-type="fig"}). The minor groove W-wedge increases the lifetime of RPo by preventing transcription bubble collapse ([Figure 6](#fig6){ref-type="fig"}). While we believe this is the dominant mode of action for CarD, CarD may affect other steps of the initiation process as well. This previously unseen mode of transcription activation may be absent in *Eco* (the focus of most mechanistic transcription studies) since *Eco* RNAP forms relatively stable complexes on most promoters ([Figure 5B](#fig5){ref-type="fig"}) ([@bib9]).

Materials and methods {#s4}
=====================

Crystallization of *Thermus* CarD/RNAP holoenzyme/promoter complexes {#s4-1}
--------------------------------------------------------------------

Crystals of *Taq* Δ1.1σ^A^-holoenzyme/promoter complexes were grown as described ([@bib5]). *Tth* CarD (prepared as described previously; [@bib44]), in 1 mM in 20 mM Tris-HCl, pH 8.0, 0.2 M NaCl, was added directly to the hanging drops containing RPo crystals to a final concentration of 100 μM. After 1 day of incubation, the crystals were cryo-protected and frozen as described ([@bib5]).

Structure determination of *Thermus* CarD/RNAP holoenzyme/promoter complexes {#s4-2}
----------------------------------------------------------------------------

X-ray diffraction data were collected at Brookhaven National Laboratory National Synchrotron Light Source (NSLS) beamline X29. Data were integrated and scaled using HKL2000 ([@bib37]). The diffraction data were anisotropic. To compensate, isotropy was approximated by applying a positive b factor along a\* and b\* and a negative b factor along c\* ([Table 1](#tbl1){ref-type="table"}), as implemented by the UCLA MBI Diffraction Anisotropy Server (<http://services.mbi.ucla.edu/anisoscale/>) ([@bib46]), resulting in enhanced map features ([Figure 2A,C](#fig2){ref-type="fig"}).

Initial Fourier difference maps, calculated after rigid body refinement ([@bib1]) starting with the appropriate RNAP-holoenzyme/promoter complex structure ([@bib5]), revealed clear density corresponding to CarD. CarD was docked into the maps with the aid of a 2.4 Å-resolution structure of a *Tth* CarD/*Taq* β1-lobe complex (PDB ID 4XAX, [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}, [Table 2](#tbl2){ref-type="table"}, see below). The models were improved in further steps of refinement: (1) rigid body refinement of 20 individual mobile domains in RNAP and 2 domains of CarD (CarD-RID and CarD-CTD) ([@bib1]); (2) deformable elastic network refinement ([@bib42]) with noncrystallographic symmetry restraints using CNS 1.3 ([@bib7]) performed on the Structural Biology Grid portal ([@bib36]); (3) iterative cycles of manual building with COOT ([@bib14]) and refinement with PHENIX ([@bib1]). The PDBePISA server (<http://www.ebi.ac.uk/pdbe/pisa/>) was used to calculate intermolecular buried surface areas ([@bib28]).

Resolution limit and structure validation {#s4-3}
-----------------------------------------

We follow the criteria of [@bib26], as explained in the accompanying paper ([@bib5]).

In the final 2*F*~o~ − *F*~c~ electron density maps, the CarD-W86 side chain was clearly resolved ([Figure 2A](#fig2){ref-type="fig"}). To confirm the side chain position, we produced an unbiased difference Fourier map using a simulated annealing omit procedure. The CarD-W86 side chain was removed from the structural model by mutation to Ala, and the mutated models were subjected to simulated annealing refinement (2500 K) using PHENIX ([@bib1]) ([Figure 2C](#fig2){ref-type="fig"}).

Crystallization of *Thermus* CarD/β1-lobe complex {#s4-4}
-------------------------------------------------

The plasmids pET21a *Taq*β1 ([@bib48a]) and pETsumo*Tth*CarD ([@bib44]) were separately transformed into *Eco* BL21(DE3) cells (EMD Millipore, Billerica, MA, United States) and transformants were grown at 37°C in Luria--Bertani media containing ampicillin (200 µg/ml) and kanamycin (50 µg/ml). At an A~600nm~ between 0.6--0.8, the cultures were supplemented with isopropyl-β,D-thiogalactopyranoside (0.5 mM final concentration) to induce protein expression for 4 hr at 30°C. The cells were then spun down by centrifugation and resuspended in buffer A (20 mM Tris-HCl, pH 8.0 at 4°C, 500 mM NaCl, 5 mM imidazole, 5% (vol/vol) glycerol, 1 mM β-mercaptoethanol). The cells were lysed using a continuous-flow homogenizer (Avestin Inc., Ottawa, ON, Canada) and then centrifuged to remove insoluble debris. The clarified cell lysate containing overexpressed (His)~10~Sumo-*Tth* CarD was first applied to a Ni^2+^-charged HiTrap column (GE Healthcare Bio-Sciences, Marlborough, MA, United States) that was equilibrated with buffer A, followed by a wash with five column volumes (cv) of buffer A + 25 mM imidazole. Subsequently, clarified cell lysate containing overexpressed *Taq* β1 was injected into the same column to form a complex with the immobilized (His)~10~Sumo *Tth* CarD. The column was washed with five column volumes (cv) of buffer A + 25 mM imidazole and 5 cv buffer A + 40 mM imidazole. The complex bound to the column was eluted with buffer A  +  250 mM imidazole. After overnight cleavage with UlpI protease (GE Healthcare) to remove the (His)~10~Sumo-tag from *Tth* CarD and dialysis against buffer A + 25 mM imidazole, a subtractive Ni^2+^-chelating chromatographic step removed uncleaved (His)~10~Sumo-*Tth* CarD and the cleaved (His)~10~Sumo-tag. The sample was concentrated and injected on a Superdex 75 gel filtration column (GE Healthcare) that was equilibrated with GF buffer (50 mM MES-OH, pH 6.5, 500 mM NaCl, 5% (vol/vol) glycerol). Fractions containing purified *Tth* CarD/*Taq* β1 complex were pooled and concentrated to 15 mg/ml by centrifugal filtration. Sodium dodecyl sulfate polyacrylamide gel electrophoresis and Coomassie blue staining were used to analyze the purity of the complex.

Crystals were grown by hanging-drop vapor diffusion by mixing 1 μl of protein solution (15 mg/ml in GF buffer) with 1 μl of crystallization solution (1.5 M ammonium sulfate, 0.1 M sodium acetate, pH 5.0, 25% (vol/vol) ethylene glycol) and incubating over a well containing crystallization solution at 22°C. Large crystals (0.5 mm) grew within 1 day. The crystals were directly frozen in liquid nitrogen for data collection.

Structure determination of the *Thermus* CarD/β1-lobe complex {#s4-5}
-------------------------------------------------------------

X-ray diffraction data were collected at Brookhaven National Laboratory NSLS beamline X29. Data were integrated and scaled using HKL2000 ([@bib37]) ([Table 1](#tbl1){ref-type="table"}).

Initial electron density maps were calculated by molecular replacement using Phaser ([@bib32]) from starting models of the *Taq* β1-lobe (2.9 Å-resolution; 3MLQ; [@bib48a]) and *Tth* CarD (2.4 Å-resolution; 4L5G; [@bib44]). One CarD/β1-lobe complex was clearly identified in the asymmetric unit. The model was first adjusted manually using COOT ([@bib14]), then further refined using the Autobuild feature of PHENIX ([@bib1]). At this point, the model fit well to the electron density but the *R*~free~ and *R* factors remained relatively high (\>0.3). Twinning was identified by Xtriage in PHENIX (twinning operators −k, −h, −l; twinning fraction 0.42). The final model was obtained after twinning refinement using PHENIX.

Promoter DNA used in biochemical assays {#s4-6}
---------------------------------------

To prepare the promoter DNAs, fragment −86 to +70 of pUC57-*MtbrrnA*P3 (−60 to +15 of the endogenous promoter sequence) was prepared as described ([@bib9]). Fragment −171 to +69 of pRLG6768-*Tthrrn23S* (−68 to +15 of the endogenous promoter sequence) ([@bib47]) was prepared similarly to AP3. These fragments (AP3 and 23S) served as templates for all transcription assays unless otherwise noted. AP3 −12T substitutions were synthesized (GenScript, Piscataway, NJ, United States) and placed into pUC57 and prepared as described for AP3 ([@bib9]). Artificial bubble and double-stranded templates of 23S (−60 to +20) were synthesized as oligonucleotides and gel purified (IDT; [Figure 6A](#fig6){ref-type="fig"}). The purified oligonucleotides were annealed and used as templates for assays.

KMnO~4~ footprinting {#s4-7}
--------------------

KMnO~4~ footprinting on the *Mtb rrnA*P3 promoter ([Figure 1D](#fig1){ref-type="fig"}) was performed as described ([@bib9]) except reactions were at 65°C with 100 mM NaCl.

Transcription assays {#s4-8}
--------------------

Abortive initiation assays ([Figure 3](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}, [Figure 4D](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}, [Figure 5B](#fig5){ref-type="fig"}, [Figure 5C](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}, [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}, [Figure 6B](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}) were performed as previously described ([@bib44]; [@bib9]) with the following adaptations for the *Thermus* transcription system. Briefly, reactions were performed in transcription buffer (10 mM Tris-HCl, pH 8.0, 1 mM MgCl~2~, 0.1 mM DTT, 50 μg/ml BSA) with 100 mM NaCl for the AP3 promoter or 100 mM K-glutamate for the 23S promoter, at 65°C. Core RNAP (200 nM) and σ^A^ (1 μM) were combined and incubated at 65°C for 5 min to form holoenzyme. CarD (2 μM, when used) was then added to the holoenzyme and incubated for an additional 5 min. Next, promoter DNA (10 nM) was added and RPo was allowed to form for 15 min at 65°C. Abortive transcription was initiated by the addition of an NTP mix containing the initiating dinucleotide (250 μM, GpU for AP3, UpG for 23S; TriLINK), the next NTP (α-^32^P-labeled, UTP for AP3, CTP for 23S; 1.25 μCi, with 50 μM of the same unlabeled NTP) and 2 μM of FC-bubble competitor DNA when used ([Figure 1D](#fig1){ref-type="fig"}) ([@bib9]). After 10 min, transcription was quenched and analyzed as previously described ([@bib9]). For half-life assays, competitor was first added and NTP substrates were added at different times as indicated ([Figures 5B,C, 6B](#fig5 fig6){ref-type="fig"}).

*Mtb* CarD substitution mutants {#s4-9}
-------------------------------

Single amino acid substitutions of CarD W86 were generated using site-directed mutagenesis (Stratagene-Agilent Technologies, Santa Clara, CA, United States) and purified using the same procedure as wild-type CarD ([@bib44]). *Mtb* CarD2C (P12C/G99C) was also made using site-directed mutagenesis but was subjected to two additional purification steps. Tandem Q-sepharose column chromatography (GE Healthcare) was used to remove inter-molecular cross-linked CarD. Sample was first applied on a 5 ml column and eluted using a NaCl gradient from 200 mM to 1 M over 20 column volumes (cv). The purest fractions were combined and reapplied to a second 5 ml Q column and eluted using a NaCl gradient from 100 mM to 1 M over 40 cv. This purification yielded \>95% intra-molecular cross-linked CarD as verified by non-reducing SDS-PAGE ([Figure 3C](#fig3){ref-type="fig"}) and liquid chromatography-mass spectromety-MS analysis (The Rockefeller University Proteomics Resource Center). Transcription assays with *Mtb* CarD were performed similarly to the *Thermus* assays in the same transcription buffer but at 37°C with 10 mM K-Glutamate rather than 100 mM NaCl. Transcription at reducing conditions included 5 mM DTT, at oxidizing conditions no DTT was present.

Accession numbers {#s4-10}
-----------------

The structure factor files and X-ray crystallographic coordinates have been deposited in the Protein Data Bank under ID codes 4XLS (*Tth* CarD/*Taq* holoenzyme/us-fork (− 12 bp) complex), 4XLR (*Tth* CarD/*Taq* RPo), and 4XAX (*Tth* CarD/*Taq* β1-lobe).
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The reviewers have discussed the reviews with one another, and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The structure of an open complex of *Thermus aquaticus* RNAP with the CarD transcription factor (which conveniently diffused into crystals of the *Taq* RPo) shows that its C-terminal domain contacts the upstream fork. A hinge between the CTD and the domain that binds the β1-lobe allows the former to dock into the fork. Various biochemical measurements support the interpretation that CarD increases the RPo lifetime. This work rationalizes divergent structures in the literature: by using disulfide bond formation they validate that *Tth* CarD structure in the open complex reported here, accurately reflects that of the active form of Mycobacterium tuberculosis CarD. The authors further validate the structure by showing that: (a) KMnO~4~ footprinting indicates that DNA structure is unchanged but that the open complex is more stable, (b) CarD has no stimulatory effect on the open bubble construct and (c) the T is preferred at the -12 non-template position, over any other base as surmised from suggested contact between the crucial W86 residue. The authors also explore the effects of substituting other aromatics or branched chain amino acids at the Cα position. That some of this characterization has already been performed with the mycobacterial enzyme provides evidence for the generality of the mode of action of CarD.

Essential revisions:

1\) Throughout the study, Bae et al. use a total of three promoters (full con promoter for structural studies with mismatch bubble, 23S promoter and AP3 promoter). It is not always clear why a certain promoter was used for a certain experiment (e.g. [Figure 3](#fig3){ref-type="fig"}). The authors make use of the 23S and the AP3 promoter for their biochemical assays, but do not provide any biochemical data for the full con promoter that was used for the structural studies. The authors should explain why the full con promoter (without the mismatch bubble) wasn\'t used in addition to the 23S and AP3 promoter to validate the structural results. For easier comparison of the different promoters (full con, 23S and AP3), please provide one figure with alignments of the different promoters.

2\) The abortive transcription assays ([Figure 3-6](#fig3 fig4 fig5 fig6){ref-type="fig"}) only show the trinucleotide transcription product. Were there any further run-off products observed due to mismatch incorporation ("leaky transcription")? We urge the authors to provide the full gel or to state whether they detected mismatch incorporation.

3\) To increase clarity of the overall presentation, the authors should provide an additional (supplemental) figure showing a protein sequence alignment of CarD from different organisms, to support the claim that CarD residue W86 is universally conserved.

4\) In the same vein, it would be good to see the distribution of CarD. Is it present in all gram positives (+ mycobacteria) and absent in all gram negatives?

5\) The authors claim that CarD "does not alter the transcription bubble" by providing data from a KMnO~4~ footprinting assay ([Figure 1D](#fig1){ref-type="fig"}). The authors should clarify: a potassium permanganate footprinting assay provides information about the general accessibility of a thymine base, but it does not provide information about the CarD dependent conformational differences (e.g. base flipping) of KMnO~4~ accessible thymine bases. The wording should be changed to reflect this distinction.

6\) The polymerase element β1-lobe is not defined in the manuscript. Which residues does it contain? Do we understand correctly that this domain corresponds to the eukaryotic RNAP II protrusion domain? Please clarify in the text, because the eukaryotic RNAP II Rpb2 "lobe" flanks the downstream cleft and thus is different from the bacterial "lobe" -- the nomenclature can lead to confusion.

7\) We recommend that the authors acknowledge that the CarD mechanism could be more complex and affect additional steps in the RPo formation.

8\) Is it possible to further probe the W86-T~-12~ (nt) interaction? For example, phenylalanine activates significantly-would it be expected to make the same contact, or to change the base preference? If so, would it be informative to look at other bases in the T~-12~ (nt) position?

9\) CarD was originally described as an rRNA regulator in response to nutrient deprivation, mediating the stringent response. Now that we know the mode of action of CarD, it would be good to return to that phenotype, and describe how it might fit in.

10\) There is considerable redundancy, both within this paper and with the accompanying paper on RPo. The authors should simply cross-reference and shorten the present manuscript to eliminate internal redundancy.

10.7554/eLife.08505.024

Author response

*Essential revisions*:

*1) Throughout the study, Bae et al. use a total of three promoters (full con promoter for structural studies with mismatch bubble, 23S promoter and AP3 promoter). It is not always clear why a certain promoter was used for a certain experiment (e.g.* [*Figure 3*](#fig3){ref-type="fig"}*). The authors make use of the 23S and the AP3 promoter for their biochemical assays, but do not provide any biochemical data for the full con promoter that was used for the structural studies. The authors should explain why the full con promoter (without the mismatch bubble) wasn\'t used in addition to the 23S and AP3 promoter to validate the structural results. For easier comparison of the different promoters (full con, 23S and AP3), please provide one figure with alignments of the different promoters*.

The full con promoter sequence was derived from an in vitro evolution (SELEX) protocol optimizing for binding to *Eco* RNAP σ^S^-holoenzyme, but subsequent analysis indicated the sequence appeared to be optimized for binding σ^70^-holoenzyme as well ([@bib17]). Because of the extremely high conservation of primary σ's (such as *Eco* σ^70^ and *Taq* σ^A^), the sequence is almost certainly optimized for binding *Taq* σ^A^ -holoenzyme as well. We use this sequence for many of our structural studies to achieve high-affinity, homogeneous complexes important for crystallization. The promoter is extremely active in abortive initiation assays but is actually a poor promoter in vitro and in vivo in run-off assays since there is an issue with promoter escape (RNAP is bound too tightly to the promoter). Because of these properties, the promoter is unlikely to be regulated (it's already as active as it can be in abortive initiation) and we generally don't use it for transcription assays, etc.

AP3 is a native *Mtb* rRNA promoter -- its regulation by *Mtb* CarD has already been extensively studied ([@bib44]; [@bib9]). In order to analyze more than one promoter (i.e. to show that the effects of CarD are not promoter-specific), we also studied 23S, a native *Tth* rRNA promoter. In each promoter-based assay, the effects of CarD on each promoter were qualitatively the same. In general, we present the results from *Tth* 23S since most of the studies used Thermus Eσ^A^ and CarD. In some cases, it was advantageous to use *Mtb* AP3 instead, and the rationale for using *Mtb* AP3 in each of these cases was as follows:

a\) For the KMnO~4~ assays ([Figure 1D](#fig1){ref-type="fig"}), we show the results from the AP3 promoter because there are more thymines in the t-strand DNA within the expected transcription bubble (3 T's for AP3, only 1 for 23S).

b\) We have included a paragraph (end of the Introduction) explaining the use of the three promoter sequences.

c\) We have added a sentence explaining the use of *Mtb* AP3 for [Figure 3B](#fig3){ref-type="fig"} (in the subsection "Role of a conserved CarD Trp residue in CarD function"): "We used *Mtb* AP3 for this analysis since *Tth* Eσ^A^ was much more active on this promoter than on *Tth* 23S, allowing us to analyze the much weaker activity of the mutant promoters".

d\) For [Figure 4D](#fig4){ref-type="fig"} (testing the function of *Mtb* CarD2C under oxidizing and reducing conditions), we used a mycobacterial transcription system ([@bib44]; [@bib9]) so we used the *Mtb* AP3 promoter (see subsection "The Thermus CarD/RNAP initiation complex structures represent the active conformation of CarD").

We have included an alignment of all three promoters ([Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}).

*2) The abortive transcription assays (*[*Figure 3-6*](#fig3 fig4 fig5 fig6){ref-type="fig"}*) only show the trinucleotide transcription product. Were there any further run-off products observed due to mismatch incorporation ("leaky transcription")? We urge the authors to provide the full gel or to state whether they detected mismatch incorporation*.

Abortive initiation assays were initiated using specific dinucleotide primers in the presence of only the next α-^32^P-NTP (for AP3, 250 µM GpU + 50 µM α-^32^P-UTP; for 23S, 250 µM UpG + 50 µM α-^32^P-CTP, see Materials and methods). The dominant products were the expected products (GpUp\*U for AP3, UpGp\*C for 23S). We have included the full, annotated gels in the supplementary figures ([Figure 3--figure supplement 1](#fig3s1){ref-type="fig"}, [Figure 4--figure supplement 1](#fig4s1){ref-type="fig"}, [Figure 5--figure supplement 1](#fig5s1){ref-type="fig"}, [Figure 5--figure supplement 2](#fig5s2){ref-type="fig"}, [Figure 6--figure supplement 1](#fig6s1){ref-type="fig"}).

*3) To increase clarity of the overall presentation, the authors should provide an additional (supplemental) figure showing a protein sequence alignment of CarD from different organisms, to support the claim that CarD residue W86 is universally conserved*.

We have previously published a CarD alignment ([@bib44]) based on 452 sequences that represented the six diverse groups of bacteria in which CarD is found. This paper also showed the phylogenetic distribution of CarD and the frequency of CarD's occurrence in these groups. To update and extend this analysis, we searched the updated database within each listed phylum (<http://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE_TYPE=BlastSearch&BLAST_SPEC=MicrobialGenomes>) and discovered that CarD is even more widely distributed than originally described (Srivastav et. al., 2013), occurring in 11 of 26 bacteria phyla searched. We now include a table documenting our findings (Supplementary file 1). We also include an alignment of CarD from 11 major subgroups, mostly grouped by phylum, but also dividing the proteobacteria in subgroups to show diversity within that phylum

([Figure 2--figure supplement 1](#fig2s1){ref-type="fig"}). We also include a large data supplemental file (Supplementary data file 1) containing an alignment of 831 CarD sequences.

4\) In the same vein, it would be good to see the distribution of CarD. Is it present in all gram positives (+ mycobacteria) and absent in all gram negatives?

Please see response to point 3.

*5) The authors claim that CarD "does not alter the transcription bubble" by providing data from a KMnO*~*4*~ *footprinting assay (*[*Figure 1D*](#fig1){ref-type="fig"}*). The authors should clarify: a potassium permanganate footprinting assay provides information about the general accessibility of a thymine base, but it does not provide information about the CarD dependent conformational differences (e.g. base flipping) of KMnO*~*4*~ *accessible thymine bases. The wording should be changed to reflect this distinction*.

The claim that CarD "does not alter the transcription bubble" is primarily based on comparison of the RPo structure (accompanying paper) and the CarD/RPo structure, as illustrated in [Figure 1--figure supplement 6](#fig1s6){ref-type="fig"}, not the KMnO~4~ footprinting data ([Figure 1D](#fig1){ref-type="fig"}). The KMnO~4~ footprinting data ([Figure 1D](#fig1){ref-type="fig"}), obtained in solution assays, supports the structural observations (from crystals). We state that: "The KMnO~4~ reactivity of thymine (T) bases within the transcription bubble is identical in the presence or absence of CarD ([Figure 1D](#fig1){ref-type="fig"}, lanes 2 and 3), supporting the structural observation that the transcription bubble is the same with or without CarD". This statement does not imply any structural over interpretation of the KMnO~4~ footprinting data. This paragraph (subsection "The CarD-CTD interacts with the upstream ds/ss junction of the transcription bubble"), and this statement in particular, seems sufficiently clear and we have not revised the text significantly here.

*6) The polymerase element β1-lobe is not defined in the manuscript. Which residues does it contain? Do we understand correctly that this domain corresponds to the eukaryotic RNAP II protrusion domain? Please clarify in the text, because the eukaryotic RNAP II Rpb2 "lobe" flanks the downstream cleft and thus is different from the bacterial "lobe" -- the nomenclature can lead to confusion*.

We have clarified that the bacterial RNAP β1-lobe corresponds to the eukaryotic RNAP II Rbp2 protrusion domain (in the fourth paragraph of the Introduction) and we have denoted the residues in the legend to [Figure 1B](#fig1){ref-type="fig"} (where the β1-lobe is first identified).

*7) We recommend that the authors acknowledge that the CarD mechanism could be more complex and affect additional steps in the RPo formation*.

We agree with the reviewers and have added that CarD could potentially affect other steps in the transcription initiation steps (please see the Discussion).

*8) Is it possible to further probe the W86-T*~*-12*~ *(nt) interaction? For example, phenylalanine activates significantly-would it be expected to make the same contact, or to change the base preference? If so, would it be informative to look at other bases in the T*~*-12*~ *(nt) position?*

We probed the interaction by mutating W86 to other hydrophobic residues and showed that activation is considerably diminished but not abolished. An F (Phe) substitution shows partial activation (∼1.6 fold versus 3 fold by wild-type CarD). We hypothesize this is due to the loss of contact between the Nԑ of W86 and O2 of the thymine base. An F substitution is able to activate better than the branched or smaller hydrophobic residues because it is more similar structurally to a W. We find substituting the -12T with other bases also diminishes activation to the same extent as an F substitution (∼1.25 to 1.7 versus 3.2 fold), supporting our hypothesis that the loss of interaction between W86 and the -12T reduces the fold- activation roughly 2 fold. We have added this observation to the manuscript (in the subsection "Role of a conserved CarD Trp residue in CarD function").

*9) CarD was originally described as an rRNA regulator in response to nutrient deprivation, mediating the stringent response. Now that we know the mode of action of CarD, it would be good to return to that phenotype, and describe how it might fit in*.

CarD was indeed originally described as a rRNA regulator in response to nutrient deprivation ([@bib45]). Subsequently, we discovered that CarD is a highly expressed gene that is present at almost all promoters during exponential growth ([@bib44]) and so we consider it to be part of the basal transcription machinery in mycobacteria. CarD is expressed at even higher levels during nutrient deprivation, oxidative and genotoxic stress ([@bib45]) -- it certainly regulates rRNA transcription in those circumstances, but it 'regulates' almost all other genes as well. Previously, we addressed the problems with the initial interpretations of the physiological effects of depleting CarD (CarD is essential so it cannot be knocked out) -- because CarD is essential, highly expressed, and regulates almost all promoters, depleting CarD causes pleiotropic effects that make it impossible to ascribe direct, specific effects ([@bib44]). We have revised the manuscript to clarify this point (in the Introduction).

*10) There is considerable redundancy, both within this paper and with the accompanying paper on RPo. The authors should simply cross-reference and shorten the present manuscript to eliminate internal redundancy*.

We have removed significant redundancy with the accompanying paper, mainly in the Materials and methods.

[^1]: Phyla list based on the list of prokaryotic names with standing in nomenclature (LPSN) (<http://www.bacterio.net/-classifphyla.html>) and the NCBI taxonomy list (<http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi>). The diverse phylum proteobacteria are divided into subgroups of α, β, γ, δ and ε.

[^2]: Genomes and draft assemblies sequenced list are shown to illustrate representation of each phylum in the Blast database and gathered from <http://www.ncbi.nlm.nih.gov/genomes/MICROBES/microbial_taxtree.html>.

[^3]: Phyla containing CarD are highlighted in bold.

[^4]: Method: Using the Blast database search engine (<http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastp&PAGE_TYPE=BlastSearch&LINK_LOC=blasthome>) we searched for sequences similar to *Tth* CarD with restrictions of amino acid length of 120:200 amino acids within each phylum.

[^5]: Values in parentheses are for highest-resolution shell.

[^6]: ([@bib11]).

[^7]: ([@bib26]).

[^8]: As determined by the UCLA MBI Diffraction Anisotropy Server (<http://services.mbi.ucla.edu/anisoscale/>).
